2013
DOI: 10.1126/science.1230582
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents

Abstract: Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for the treatment of cancer. Despite the importance of MSAs for medical applications and basic research, their molecular mechanisms of action on tubulin and microtubules remain elusive. Here we determined high-resolution crystal structures of aß-tubulin in complex with two unrelated MSAs, zampanolide and epothilone A. Both compounds were bound to the taxane-pocket of ß-tubulin and used their respective side chain to induce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

37
618
4
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 428 publications
(660 citation statements)
references
References 30 publications
37
618
4
1
Order By: Relevance
“…MTAs are divided into two general categories: microtubule-stabilizing and -destabilizing agents (Hartley et al, 2012). Microtubule-stabilizing agents, represented by taxol-like compounds, bind to the lateral side of tubulin, stabilizing the M-loop of b-tubulin, which establishes the lateral contacts of tubulin in microtubules (Prota et al, 2013a). Microtubule-destabilizing agents bind to the longitudinal interface between the a/b-tubulin subunits, causing conformational shifts of consecutive a-, b-tubulin heterodimers from a straight to a curved form, facilitating microtubule disassembly (Ravelli et al, 2004;Gigant et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…MTAs are divided into two general categories: microtubule-stabilizing and -destabilizing agents (Hartley et al, 2012). Microtubule-stabilizing agents, represented by taxol-like compounds, bind to the lateral side of tubulin, stabilizing the M-loop of b-tubulin, which establishes the lateral contacts of tubulin in microtubules (Prota et al, 2013a). Microtubule-destabilizing agents bind to the longitudinal interface between the a/b-tubulin subunits, causing conformational shifts of consecutive a-, b-tubulin heterodimers from a straight to a curved form, facilitating microtubule disassembly (Ravelli et al, 2004;Gigant et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…Peloruside, another MSA under development as an anticancer agent, is particularly interesting because unlike the other newgeneration MSAs discussed above, peloruside binds to a unique, non-taxoid site on b-tubulin that it shares with another marine sponge natural product, laulimalide (10,(13)(14)(15). In addition, peloruside and laulimalide, similar to the epothilones and discodermolide, retain their activity in cells that overexpress the P-gp efflux pump (13,14), thus remaining active in cells that have acquired resistance to the taxanes by P-gp overexpression.…”
Section: Introductionmentioning
confidence: 99%
“…All taxanes bind to the same or to an overlapping taxoid-binding site on b-tubulin, located on the inner surface of the microtubule (27,28). Taxanes and other microtubule-targeting drugs inhibit cancer cell proliferation by binding to microtubules and suppressing microtubule dynamics during the particularly vulnerable mitotic stage of the cell cycle without significantly altering the mass or organization of microtubules (26).…”
Section: Introductionmentioning
confidence: 99%